- Japanese descent male and female adults who do not have the potential to bear children
>= 50 years of age.
- Determined to be eligible for the study based on medical history, physical
examination, and clinical judgment. Subjects with preexisting stable disease, defined
as disease not requiring significant change in therapy or hospitalization for
worsening disease 12 weeks before receipt of study vaccine, are eligible.
- Sexually active men must agree and commit to use a medically accepted form of
contraception during the study and for at least 3 months after vaccination.
- History of severe adverse reaction associated with a vaccine.
- Receipt of any vaccine within 30 days before study vaccination, except influenza
vaccine.
- Documented S pneumoniae infection within the past 5 years before study vaccination.